Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 3 3Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Head & Neck 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Colorectal Neoplasms 749Pancreatic Neoplasms 664Stomach Neoplasms 386Carcinoma, Non-Small-Cell Lung 373Carcinoma, Hepatocellular 367Breast Neoplasms 316Colonic Neoplasms 279Ovarian Neoplasms 259Neoplasms 250Esophageal Neoplasms 236Neoplasm Metastasis 215Rectal Neoplasms 202Melanoma 195Lung Neoplasms 193Liver Neoplasms 180Squamous Cell Carcinoma of Head and Neck 149Carcinoma, Renal Cell 145Head and Neck Neoplasms 124Prostatic Neoplasms 123Triple Negative Breast Neoplasms 108Urinary Bladder Neoplasms 106Uterine Cervical Neoplasms 105Cholangiocarcinoma 102Endometrial Neoplasms 100Sarcoma 99Gastrointestinal Neoplasms 73Small Cell Lung Carcinoma 72Esophageal Squamous Cell Carcinoma 68Kidney Neoplasms 63Carcinoma, Transitional Cell 59

Interventions

Poly I-C 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Neoplasm Recurrence, Local × Gastrointestinal × Clear all
NCT00094003 2005-11-11

Study of NS-9 in Patients With Liver Metastases

NS Pharma, Inc.

Phase 1 Completed
20 enrolled
BreastDermatologicGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Esophageal Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Neoplasm Recurrence, Local, Skin Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡